Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
NANOBAC PHARM (NNBP) had Return on Investments of 50.00% for the most recently reported fiscal quarter, ending 2007-12-31.
| Income Statement Financials | |
$-0.00M |
|
$-1.18M |
|
-- |
|
$-0.00M |
|
$1.17M |
|
$-1.17M |
|
$-0.04M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.17M |
|
$-1.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.03M |
|
$0.16M |
|
$7.31M |
|
$7.22M |
|
$6.74M |
|
-- |
|
$2.83M |
|
$9.58M |
|
$-2.36M |
|
$-9.50M |
|
$-2.36M |
|
-- |
|
| Cash Flow Statement Financials | |
$-0.91M |
|
$0.04M |
|
$0.91M |
|
$0.04M |
|
$0.00M |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-1.75 |
|
-- |
|
39100.00% |
|
39100.00% |
|
-- |
|
39333.33% |
|
39333.33% |
|
$-0.91M |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-1.50 |
|
-60.00 |
|
50.00% |
|
12.42% |
|
-16.34% |
|
|
Return on Investments |
50.00% |
-- |
|
-- |
|
-- |
|